Tetratherix Ltd
Research Tetratherix Ltd (TTX) on Bullrun: market cap AUD 368.22M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTTX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryBiotechnology
- CurrencyAUD
- Market capAUD 368.22M
- Financial periodFY2025
- RevenueAUD 1.05M
- Revenue growth22.1%
- Net income-AUD 9.43M
- Free cash flow-AUD 3.27M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 368.22M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 1.05M | -AUD 9.43M | -AUD 3.27M | 100.0% | -0.36 | AUD 29.34M | AUD 2.04M | AUD 27.25M |
| FY2024 | AUD 860.00K | -AUD 4.52M | -AUD 4.53M | 100.0% | -0.09 | AUD 130.00K | AUD 7.74M | AUD 0 |
| FY2023 | AUD 570.00K | -AUD 3.98M | -AUD 2.55M | 70.2% | -0.08 | AUD 260.00K | AUD 5.24M | AUD 0 |
| FY2022 | AUD 1.11M | -AUD 1.54M | -AUD 820.00K | 82.9% | n/a | AUD 10.00K | AUD 4.48M | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-12 | AUD 368.22M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical devices in the areas of bone regeneration, tissue spacing, tissue regeneration, and precision medicine applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tetratherix Ltd's market cap?
Tetratherix Ltd's market capitalization is AUD 368.22M.
What does Tetratherix Ltd do?
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical devices in the areas of bone regeneration, tissue spacing, tissue regeneration, and precision medicine applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.